Article Details
Retrieved on: 2018-09-04 22:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Fulcrum launched in 2016 with a $55 million Series A from <b>Third Rock Ventures</b>. Other pipeline compounds focus on sickle cell disease, Duchenne ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here